NIH-funded research NIH-funded research

Consortium improving care for eosinophilic gastrointestinal diseases

Official title: Consortium of Eosinophilic Gastrointestinal Disease Researchers

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11464389 · Data updated 2026-11-12

A network of clinics is working together to advance care for adults with rare eosinophilic gut diseases like eosinophilic gastritis, enteritis, and colitis, with patient needs and trial readiness at the forefront.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startAugust 15, 2014
Project endJuly 31, 2031
Funding year2026
Award (this year)$1,715,911
NIH project number2U54AI117804-11
Project IDNIH-11464389 on NIH RePORTER

Who could benefit from this research

Could help

Adults (21+ years) with eosinophilic gastritis, enteritis, or colitis who seek collaborative, translational research participation.

Less likely to help

Individuals without these specific EGID conditions or not enrolled in clinical-trial-ready research may not directly benefit.

What this research studies

CEGIR is a nationwide, multi-center effort that brings together adult patients with eosinophilic GI diseases to build translational clinical research. The consortium emphasizes collaboration across specialties and sites, merging pediatric and adult perspectives to create unified care pathways. Through patient-centric research, CEGIR aims to prepare for future clinical trials and accelerate translation of findings into real-world treatment options. This grant supports continued collaboration, data sharing, and mentorship to sustain progress in understanding and managing these rare conditions.

Why it matters

Potential benefit: If successful, patients could see faster development of effective treatments and better-informed care strategies for eosinophilic GI diseases.

How similar studies have gone: Previous CEGIR collaborations have demonstrated productive multi-site clinical and translational work in EGID.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Rothenberg, Marc E. — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Rothenberg, Marc E.

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.